(Q34418106)

2 August 2017

0 references

1 reference

title

Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential (English)

1 reference

2 August 2017

0 references

P Gallagher

3

0 references

author name string

C H Ashton

series ordinal

1

1 reference

2 August 2017

P B Moore

series ordinal

2

1 reference

2 August 2017

A H Young

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Journal of Psychopharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

19

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

293-300

1 reference

Endocannabinoids: getting the message across

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

The effects of cannabinoids on the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Causal association between cannabis and psychosis: examination of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Adverse effects of cannabis and cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

GABA-ergic drugs: exit stage left, enter stage right

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

The seed and the soil: effect of dosage, personality and starting state on the response to delta 9 tetrahydrocannabinol in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Drug abuse and bipolar disorder: comorbidity or misdiagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Substance abuse in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Neurobiology Cannabinoids act backwards

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Suicide risk in bipolar patients: the role of co-morbid substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Subgenual prefrontal cortex abnormalities in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Cognitive impairment in bipolar affective disorder: implications for the bipolar diathesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

A single dose study of nabilone, a synthetic cannabinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Do patients use marijuana as an antidepressant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Antianxiety effect of cannabidiol in the elevated plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Psychiatric effects of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

The pharmacological treatment of bipolar affective disorder: practice is improving but could still be better

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Nabilone in the treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Health consequences of acute and chronic marihuana use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Cannabis and Cannabis Extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Cannabidiol: an overview of some pharmacological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Does quetiapine have mood altering properties?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Hypnoticlike effects of cannabidiol in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

A review of recent advances in cannabinoid research and the 1994 International Symposium on Cannabis and the Cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Pharmacology of cannabinoid CB1 and CB2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Cannabinoid receptors and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Neurobiology of emotion perception II: Implications for major psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

The endocannabinoid system as a target for therapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Endocannabinoids: a new class of vasoactive substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Cannabis-associated psychosis with hypomanic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex--involvement of Na(+)/K(+)-ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Brain magnetic resonance imaging of structural abnormalities in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

The impact of substance abuse on the course of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Biphasic effects of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Cannabinoids in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Alcoholism and drug abuse in three groups--bipolar I, unipolars and their acquaintances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Psychosis due to "skunk".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

Drug Abuse in Schizophrenia and Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105051541

21 January 2018

Identifiers

DOI

10.1177/0269881105051541

1 reference

2 August 2017

1 reference